FTC Takes Action Against Purported COVID-19 Supplement
By EsqSocial Corporation 02/11/20
Since the COVID-19 pandemic began, the Federal Trade Commission (FTC) has cracked down on companies purporting to sell products that can alleviate or prevent symptoms of COVID-19. Recently, the FTC announced its approval of a final administrative consent order that settled charges against a marketer of a supplement called “Thrive,” which was advertised as being able to treat, prevent, or reduce the risk of COVID-19......
By: Fox Rothschild LLP